Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

NEXT STORY
South Africa Nutraceuticals Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)
PREV STORY
Pharmaceutical Drugs Market Players Focus On Digital Solutions To Mitigate Long-Term Risks In Terms Of The COVID-19 Impact
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Initiation of Phase 2 Clinical Trial to Evaluate Tedopi® in Combination with Opdivo® (nivolumab) in Pancreatic Cancer

The trial, sponsored and conducted by oncology group GERCOR, will be supported by Bristol-Myers ...

author_avatar
NASDAQ Market News

G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

author_avatar
NASDAQ Market News

Agios to Webcast Conference Call of Second Quarter 2018 Financial Results on August 2, 2018

CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader ...

author_avatar
NASDAQ Market News